In order to address the disparity in available diabetes information, RCN has designed and funded a research study to assess the glycemic status of 400 adults residing in four (4) towns (Awka-etiti, Nnobi, Obeledu and Neni) within 20 mile radius of its facility using the Hemoglobin A1c test (A1c now+ kit, Bayer(R)). This project was carried out by a team of allied health professionals which includes RISE Clinic Nigeria staff and RISE Clinic Nigeria volunteers.
HA1c test provides quantitative measurement of the percent of glycosylated hemoglobin (%A1c) levels in capillary (fingerstick) or venous whole blood samples. The test is for professional use to monitor glycemic control in people with diabetes. The correlation of A1c and blood glucose levels make it a useful method of monitoring long term blood glucose levels in people with diabetes.3 Studies have shown that tight glycemic control is associated with fewer diabetes- related complications.4
In addition to HA1c assessment, participants’ demographic information, literacy level, vital signs and basic diabetic examinations eg. Diabetic foot exam were assessed.
The research shall have an experimental research study design. This design will assess and evaluate the glycemic control of the adult population 20 miles radius off RISE Clinic Nigeria Adazi ani, Anambra state.